Breaking Tech Europe: Top 5 – Nvidia Courts Arm's Rene Haas, EU Leaders Hold First AI Summit in Dublin, and Affirm Buys Berlin's Ratepay

Nvidia's leadership crisis reaches Cambridge, EU leaders sit down for their first AI summit, a US payments giant takes over a Berlin fintech, ASML's unions walk out, and a Helsinki biotech emerges from stealth. These are the five European tech stories that matter this weekend.
1. Nvidia board approaches Arm CEO Rene Haas as it looks for Jensen Huang's successor (UK)
Nvidia → Arm's Rene Haas approached as possible CEO, one day after Jensen Huang resigned → Britain's best-known chip designer could lose its chief. Nvidia's board has approached Haas, chief executive of Cambridge-based Arm Holdings, in its search for a successor to Huang, the Financial Times reported on Friday 13 November, according to Reuters. Huang stepped down on Thursday after revelations of extramarital affairs, including one involving a suspected Chinese spy. Chief financial officer Colette Kress is interim CEO.
Haas spent seven years at Nvidia before joining Arm in 2013, and he became Arm's CEO in 2022. The FT reported that he is one of several candidates and may not be offered the job or accept it. Arm declined to comment, and Reuters said it could not independently verify the report. In a statement reported by CNBC and Benzinga, Nvidia's board said it was still selecting a search firm, had "not formally engaged any potential candidates" and called speculation "premature".
Why it matters: Arm is Britain's flagship chip-design company and a key supplier of processor designs to the wider semiconductor industry. If Haas moved, Arm would need a new leader, and Nvidia would be led by a long-time Arm executive.
2. EU leaders hold their first AI summit in Dublin, with Mistral's Arthur Mensch at the table (Ireland/EU)
EU heads of government, Mistral CEO Arthur Mensch and Geoffrey Hinton meet in Dublin → first leaders' summit dedicated to AI → Europe weighs catching up with the US and China against controlling the risks. The informal summit took place on 13 November, Euronews reported with AFP. Irish Taoiseach Micheál Martin said leaders would explore "the balance between regulation and innovation" and tech sovereignty.
European Parliament president Roberta Metsola said she was tired of hearing that the EU had "somehow lost the AI race". EU foreign-policy chief Kaja Kallas warned of a "dark side of AI", pointing to AI-equipped drones in Ukraine. In a letter this week, Estonia and Finland called for "EU-level arrangements for responding to serious AI incidents". An EU official told AFP that the Nvidia scandal was not formally on the agenda but could still be raised.
Why it matters: With Mistral, Europe's leading model developer, in the room, the Dublin meeting shows that AI has moved from a regulatory file to a question of industrial and security strategy for heads of government.
3. Affirm buys Berlin's Ratepay from Nexi, and job cuts follow within hours (Germany)
Affirm buys Ratepay from Nexi, price undisclosed → Berlin BNPL provider with about 200 staff announces a restructuring → layoffs confirmed by Nexi. According to German banking outlet Finanz-Szene, Italian payments group Nexi is selling Ratepay to the US "buy now, pay later" company Affirm. The two also signed a letter of intent to expand their partnership in the DACH region. The deal is expected to close in the first half of 2027, subject to regulatory approval.
Hours after the announcement, Ratepay chief executive Sabrina Flunkert wrote on social media that "our current setup was not sustainable" and that some colleagues would leave. A Nexi spokesperson confirmed to Finanz-Szene that these are layoffs but did not say how many of the roughly 200 employees are affected. Ratepay had about 300 staff around 2021 and came under pressure after losing retailer Otto, which Finanz-Szene describes as probably its largest customer. Earlier attempts by Nexi to sell the business had failed.
Why it matters: Affirm, which Finanz-Szene describes as one of the world's largest BNPL providers and a hard competitor of Klarna in the US, gets an established German platform. For Ratepay's staff and merchants, the price of the exit is a smaller operation.
4. Dutch unions walk out of ASML talks over a delayed reorganisation (Netherlands)
CNV, De Unie and VHP2 → walk out of social-plan talks with ASML → about 1,700 job cuts face new deadlines in December and March. The unions left the talks after the chipmaking-equipment maker moved the rollout of its new organisational structure from November to December, or even March, for some groups of staff, NU.nl reported, citing confirmation given to the Eindhovens Dagblad.
The June social plan said employees declared redundant would be released from work on full pay from November to May to look for a new job. The delay squeezes that window. The unions say the changes are big enough to require new negotiations, which ASML refuses. "We do not understand this action," the company said, adding that it had offered extra mitigating measures. ASML announced in January that it would cut about 1,700 jobs, mostly management roles, and has agreed not to make forced redundancies before 1 May 2027.
Why it matters: ASML is the world's only supplier of EUV lithography machines, so a breakdown in its labour relations matters well beyond Veldhoven. The dispute has so far been reported almost only in Dutch media.
5. Helsinki's Switchpoint Bio raises $5.3m to read drug response from a blood sample (Finland)
Switchpoint Bio → $5.3m pre-seed, $5m of it from Treehouse Delmar Investments → AI and blood epigenomics to show why some patients respond to a drug and others do not. The Helsinki and Cambridge, Massachusetts start-up has emerged from stealth with the round, Tech.eu reported. Its targeted DNA-methylation assay aims to track how immune cells change during treatment, without repeated tissue biopsies.
The company was co-founded by chief executive Samuel Myllykangas, who previously built Blueprint Genetics (acquired by Quest Diagnostics in 2020), and Harvard professor Jason Buenrostro, inventor of the ATAC-seq profiling technology. It is testing its approach in systemic lupus erythematosus and is in talks with pharmaceutical companies about first validation programmes. "Our goal is to make these biological switchpoints visible from a routine blood sample," Myllykangas told Tech.eu.
Why it matters: Finland's biobank and genomics talent, including FinnGen veterans on the founding team, is producing companies that sell straight into global drug development.
Compiled by the EuropeanTechOnHeels newsroom. All figures and claims are attributed to the linked sources.




